Head-to-head comparison
Cora Health vs VyrarX
Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.
Desk Score
Cora Health is a direct-to-consumer telehealth platform offering compounded semaglutide ($99–$175/mo) and tirzepatide ($135–$225/mo) with flat per-tier pricing — no surcharge as your dose escalates.
$175/mo sema · $225/mo tirz · Verified July 2026
Marked down on: Compounded medications are not FDA-approved and not therapeutically equivalent to Wegovy/Zepbound
Desk Score
VyrarX is a LegitScript-certified telehealth platform offering compounded semaglutide (from $179/month) and compounded tirzepatide (from $329/month) via weekly injection, with provider messaging and nutrition coaching included — and no ladder published behind either "from".
From $179/mo sema · From $329/mo tirz · Verified August 2026
Marked down on: Both prices are "from" figures with nothing behind them — no ladder, no dose banding, no plan lengths — on a site whose own badge reads "Transparent pricing"
Cora Health takes this head-to-head with the higher Desk Score, 81/100 (B−) against 78/100 (C+) for VyrarX. VyrarX still holds its ground where its strengths line up with yours.
Desk Score, dimension by dimension
Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.
Cora Health
81/100
B−
VyrarX
78/100
C+
Price transparency
State access
Molecule range
Onboarding speed
Support responsiveness
Licensing & trust
The spec sheet
| Field | Cora Health | VyrarX |
|---|---|---|
| Semaglutide | $175/mo$175/mo | From $179/moFrom $179/mo (compounded; the site publishes no ladder, dose banding or term behind the word "from") |
| Tirzepatide | $225/mo$225/mo | From $329/moFrom $329/mo (compounded; the site publishes no ladder, dose banding or term behind the word "from") |
| Coverage | All 50 states | 47 states (not California, South Carolina or New Jersey) |
| Brand-name | Compounded only | Compounded only |
| Oral option | Injectable only | Injectable only |
| Best for | Flat-rate compounded GLP-1 from $99/mo with named pharmacy disclosure. | Readers outside California, South Carolina and New Jersey who want provider messaging and nutrition coaching bundled in, and will complete a five-minute intake to learn what the price becomes at their dose. |
| Desk Score | 81/100B− | 78/100C+ |
The verdict
Desk pick — Cora HealthCora Health takes this head-to-head with the higher Desk Score, 81/100 (B−) against 78/100 (C+) for VyrarX. VyrarX still holds its ground where its strengths line up with yours.
Choose Cora Health if…
Flat-rate compounded GLP-1 from $99/mo with named pharmacy disclosure.
$175/mo sema · $225/mo tirz · All 50 states
Choose VyrarX if…
Readers outside California, South Carolina and New Jersey who want provider messaging and nutrition coaching bundled in, and will complete a five-minute intake to learn what the price becomes at their dose.
From $179/mo sema · From $329/mo tirz · 47 states (not California, South Carolina or New Jersey)
Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we write about a provider reads the same either way. Read full breakdowns: Cora Health · VyrarX.
Also here
CoreAge Rx leads the whole ranking at 94/100
Whichever of these two you lean toward, our #1-rated provider outscores them both. One price at every dose, both molecules, all 50 states. The $99 and $149 figures are 12-month plans paid up front, not a monthly bill.
More head-to-heads
- Cora Health vs CoreAge Rx
- CoreAge Rx vs VyrarX
- Cora Health vs Trimi
- Trimi vs VyrarX
- Cora Health vs Elara Health and Wellness
- HealthRX vs VyrarX
Or see the full comparison hub and the complete ranking.
Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.